A New Era of Heart Repair Through Stem Cells
(Image Credit: keck.usc.edu)
(Image Credit: scitechdaily.com)
(Image Credit: stemcellforlife.com)
December 2, 2024
Jayden Chung
12th Grade
Fountain Valley High School
Imagine surviving a heart attack, only to learn that your heart’s ability to heal itself is painfully limited. For millions of people, the diagnosis of heart damage feels like a life sentence, with scar tissues replacing healthy muscle and limiting the heart’s function. But what if science could offer a second chance, a way for damaged hearts to regenerate, beating with new strength?
Unlike the skin or the liver, the heart is limited in its capability to self-repair. Following a heart attack, the damaged muscle cells are replaced with scar tissues rather than a new muscle cell. This scarring causes the heart to weaken and could potentially lead to chronic heart failure. Scientists have sought different methods to regenerate the heart’s tissues, but the highly specialized nature of heart cells makes this a challenging goal.
Stem cells hold an extraordinary ability to transform into specialized cell types, including cardiomyocytes which make up the heart muscle and are responsible for the heart’s contraction. In the lab, scientists can encourage stem cells to become heart muscle cells, which could then be used to replace damaged tissue.
There are several types of different stem cells and there are three that stand out as the most effective approach for heart regeneration which are embryonic stem cells, induced pluripotent stem cells, and mesenchymal stem cells. The embryonic stem cells can develop into any cell type including heart muscle cells, they have great regenerative potential. However, embryonic stem cells are limited due to their ethical concerns and a high possibility of immune rejection, which is the body’s immune system attacking foreign cells. The high risk of immune rejection and formation of tumors is one of the major factors why it is an inferior method of stem cell therapy compared to the mesenchymal cell and the induced pluripotent stem cell.
The mesenchymal cells are found in bone marrow, fat tissues, and other areas of the body. Mesenchymal cells can differentiate into various cell types and support tissue repair, however, they don’t convert into heart muscle cells as readily as embryonic stem cells or induced pluripotent stem cells. Mesenchymal cells show a promising result for reducing heart inflammation and stabilizing scar tissue which helps improve overall heart functions.
A specific type of stem cell that researchers have been exploring for heart therapy is called the induced pluripotent stem cell which reprograms adult cells to revert to a stem-cell-like state, scientists can create patient-specific stem cells, reducing the risk of immune rejection. The induced pluripotent stem cells are superior to the mesenchymal cells due to their unique ability to differentiate into specialized cardiomyocytes which are capable of beating and functioning like natural heart cells. Induced pluripotent stem cells are the most promising candidate for heart regeneration since they are derived from a patient’s skin or blood cells and their ability to directly replace damaged heart tissues, providing a long-term regenerative solution.
In a breakthrough study, researchers successfully transplanted lab-grown heart cells derived from induced pluripotent stem cells onto damaged heart tissue in animal models, resulting in improved cardiac function and reduced tissue scars. With this success, clinical trials in humans are underway to assess the safety and effectiveness.
There are a few complications and challenges including the need to control the differentiation process to prevent the formation of unintended cell types or tumors. Researchers are exploring advanced techniques such as gene editing and the creation of “cardiac patches” to enhance induced pluripotent stem cells' safety and integration into heart tissues. With the ongoing advancements, induced pluripotent stem cells give hope to the revolutionizing cardiac therapy by providing a safe, personalized approach to heart regeneration.
Heart regeneration and stem cell therapy are at the cutting edge of regenerative medicine, promising to change the landscape of cardiac treatment. As the science of stem cells progresses, the dream of fully healing damaged heart tissues comes closer to reality. With each breakthrough in stem cell therapy, we are closing the gap of a future where heart disease may no longer be a permanent sentence, but a challenge that we can overcome; offering a new life and hope to millions worldwide through the extraordinary potential of heart regeneration.
Reference Sources
“Center for Regenerative Biotherapeutics - Cardiac Regeneration.” Mayo Clinic,
https://www.mayo.edu/research/centers-programs/center-regenerative-biotherapeutics/focus-areas/cardiac-regeneration. Accessed 8 Nov. 2024.
Cho, Sangkyun, et al. “Reconstructing the Heart Using Ipscs: Engineering Strategies and Applications.” Journal of Molecular and Cellular
Cardiology, U.S. National Library of Medicine, Aug. 2021,
https://pmc.ncbi.nlm.nih.gov/articles/PMC8378256/.
Hare, Joshua M, and Sandra V Chaparro. “Cardiac Regeneration and Stem Cell Therapy.” Current Opinion in Organ Transplantation, U.S.
National Library of Medicine, Oct. 2008,
“How the Body Regulates Scar Tissue Growth after Heart Attacks.” UCLA Health, 3 July 2020,
Ishida, Masaru, et al. “Transplantation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Is Superior to Somatic Stem Cell
Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction.” Transplantation, U.S.
National Library of Medicine, Feb. 2019,
https://pmc.ncbi.nlm.nih.gov/articles/PMC6365242/.
Jiang, Yuqian, and Xiaojun Lance Lian. “Heart Regeneration with Human Pluripotent Stem Cells: Prospects and Challenges.” Bioactive
Materials, U.S. National Library of Medicine, 14 Jan. 2020,
https://pmc.ncbi.nlm.nih.gov/articles/PMC6965207/.
Kawamura, Takuji, et al. “Safety Confirmation of Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch Transplantation for Ischemic
Cardiomyopathy: First Three Case Reports.” Frontiers in Cardiovascular Medicine, U.S. National Library of Medicine, 15 Sept. 2023,
https://pmc.ncbi.nlm.nih.gov/articles/PMC10540447/.
Pawani, Harsha, and Deepa Bhartiya. “Pluripotent Stem Cells for Cardiac Regeneration: Overview of Recent Advances & Emerging Trends.”
The Indian Journal of Medical Research, U.S. National Library of Medicine, Feb. 2013,
https://pmc.ncbi.nlm.nih.gov/articles/PMC3657850/#:~:text=Induced%20pluripotent%20stem%20cells%20(iPSCs,%2C%20and%20c%2Dmyc113.
Ripa, Rashelle. “Physiology, Cardiac Muscle.” StatPearls [Internet]., U.S. National Library of Medicine, 30 July 2023,
“Scientists Find Way to Heal Scars Left behind by Heart Attacks.” The University of Sydney,
Shin Kadota and Yuki Tanaka, et al. “Heart Regeneration Using Pluripotent Stem Cells.” Journal of Cardiology, Elsevier, 18 July 2020,
Wong, Sharon S Y, and Harold S Bernstein. “Cardiac Regeneration Using Human Embryonic Stem Cells: Producing Cells for Future Therapy.”
Regenerative Medicine, U.S. National Library of Medicine, Sept. 2010,